1. Annual report 2023
  2. Research
  3. GRENSSAP

GRENSSAP

Research Group in Primary Health Services

This group for research into primary health care services in Catalonia is made up of a team of researchers from IDIAP Jordi Gol who have been working on various lines of health service research for serveral years, and participate in important processes of evaluation and innovation in primary health care in Catalonia (evaluation of the objectives of the Catalan Health Service, the impact of electronic guidelines, the role of nurses in the care of acute problems, evaluation of a new model for emergency services, validation of Adjusted Clinical Groups®, etc.). Many of its members participated in the redIAPP network between 2003 and 2006 or in the IRYSS network (Investigation of Results and Health Services: G03/2020). In 2006 it again joined teh redIAPP network. In 2009, it was accredited as an emergent group by the Department of Innovation, Universities and Business of the Catalan Generalitat. The general aim of the group is research into and systematic evaluation of general and specific aspects of the development and function of health services and their relationship with factors affecting health.

Group projects

R+D+I PROJECTS FUNDED IN COMPETITIVE CALLS FROM ADMINISTRATIONS OR PUBLIC AND PRIVATE ENTITIES

  • Validació amb cohorts externes d'un model predictiu longitudinal entrenat amb dades de pacients crònics - SIDIAP. (MV22/00026). Instituto de Salud Carlos III. 2022-2023. IP: Lucía Amalia Carrasco Ribelles.

  • Sara Borrell ISCIII 2021. (CD21/00124). Instituto de Salud Carlos III. 2021IP:Laura Medina Perucha.

  • Revisión sobre cohesión social: evidencia sobre la asociación entre la cohesión social/capital social y la salud, así como del abordaje e implementación de políticas públicas en dicha área. American Health Organization/World Health Organization (PAHO/OPS). 2022-2023. IP: Constanza Jacques Aviñó.

  • Quality, efficacy and safety studies on medicines, Lot 5 Pharmacoepidemiological research (V. HEBRON). European Medicines Agency (EMA). 2021-2023. IP: Maria Giner Soriano.

  • Plataforma IMPACT - Programa 2 - Ciencia de Datos. (IMP/00019). Barcelona Supercomputing Center (BSC-CNS); Instituto de Salud Carlos III. 2020-2024. IP: María Aragón Pérez.

  • Plataforma IMPACT - Programa 1 Medicina Predictiva IMP/00021. (IMP/00021). Consoricio Centro de Investigación Biomédica en RED (CIBER); Instituto de Salud Carlos III. 2020IP:Josep Basora Gallisà, Bonaventura Bolíbar Ribas.

  • Perspectiva de gènere i factors de risc cardiovascular en diabetis. ICS - Institut Català de la Salut. 2022-2024. IP: Anna Mª Ramírez Morros.

  • Mejora en la Integración Fundanet-GIR. (MDG-23-11571). Fundación Española para la Ciencia y la Tecnologia (FECYT). 2023-2026. IP: Anna Moleras Serra.

  • Kinetics of humoral immune response over 17 months of covid 19 pandemic in a large cohort of healthcare workers in spain: the PROHEPIC 19 study. Col.legi Oficial de Metges de Barcelona; Fundació Academia Ciencies Mediques de Catalunya I de Balears (L'Acadèmia). 2023 IP: Concepció Violán Fors.

  • Estratègia per potenciar el grup de recerca PROSAARU a la Catalunya Central. ICS - Institut Català de la Salut. 2023-2027. IP: Glòria Saüch Valmaña.

  • Estada Aarhus University (Denmark). Institut d'Investigació en Atenció Primària Jordi Gol i Gurina (IDIAPJGol). 2021-2023. IP: Tomàs López Jiménez.

  • DARWIN-EU. European Medicines Agency (EMA). 2022 IP: Talita Duarte Salles.

  • Construcción y validación de un Score predictivo de riesgo de institucionalización, ingresos hospitalarios y mortalidad, en mayores de 65 años con multimorbilidad y fragilidad. (FI20/00040). Instituto de Salud Carlos III. 2020-2023. IP: Lucía Amalia Carrasco Ribelles.

CONTRACTS, AGREEMENTS OR NON-COMPETITIVE R+D+I PROJECTS WITH ADMINISTRATIONS OR PUBLIC OR PRIVATE ENTITIES.

  • Teze Cardiac PASS - SIDIAP Feasibility Questionnaire. IQVIA LTD. 2023-2024. IP: Maria Giner Soriano.

  • TADIA_MED. Universitat Politècnica de Catalunya (UPC). 2020-2024. IP: Concepció Violán Fors.

  • Pla Director de Malalties Vasculars Cerebrals (AQUAS). Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS). 2020-2023. IP: Bonaventura Bolíbar Ribas.

  • Living Lab per co-crear i testar coses amb universitaris. LIVING LAB UNIVERSITARI URV. IP: Constanza Jacques Aviñó.

  • LANTITAPS. Institut d'Investigació en Atenció Primària Jordi Gol i Gurina (IDIAPJGol). 2022-2023. IP: Diana Puente Baliarda.

  • App per a mòbils per fer nistagmografíes incorporades a un algoritme diagnòstic del vertigen perifèric paroxistic benigne. NYSTAVERT. Fundació d'Atenció Primària (FAP) - CAMFIC. IP: José Luis Ballvé Moreno.

CLINICAL STUDIES

  • VITTLINK: A multi-centre international database study evaluating the association of vaccine-induced thrombosis and thrombocytopenia (VITT) with COVID-19 vaccination. 2022-2024. IP: Felipe Villalobos Martínez.

  • vACCine covid-19 monitoring readinESS (ACCESS). UMC Utrecht (University Medical Center Utrecht). 2020-2023. IP: María Aragón Pérez.

  • VAC4EU Postauthorisation Effectiveness Study of BIMERVAX® Vaccine in Europe. Research Triangle Institute (RTI). 2023-2026. IP: Felipe Villalobos Martínez.

  • Utilization and safety of antidementia treatments: a large longitudinal population-based study in Catalonia. Institut d'Investigació en Atenció Primària Jordi Gol i Gurina (IDIAPJGol). 2022 IP: Carlen Reyes Reyes.

  • Utilització de fàrmacs Insuficiència Cardíaca. Institut d'Investigació en Atenció Primària Jordi Gol i Gurina (IDIAPJGol). 2022-2024. IP: Maria Giner Soriano.

  • Uso de fármacos, medicina complementaria y vacunación en mujeres y personas embarazadas y lactantes: estudio cualitativo. 2022 IP: Laura Medina Perucha.

  • Use of hydrochlorothiazide and risk of skin cancer. Institut d'Investigació en Atenció Primària Jordi Gol i Gurina (IDIAPJGol). 2020-2023. IP: Talita Duarte Salles.

  • Urban and social environment and childhood obesity - a natural moving2health experiment. Fundacio "la Caixa". 2021 IP: Talita Duarte Salles.

  • UNravelling COVID-19 through rEal-woRld data (UNCOVER). Institut d'Investigació en Atenció Primària Jordi Gol i Gurina (IDIAPJGol). 2021 IP: Talita Duarte Salles.

  • Time trends and socioeconomic factors associated with cancer incidence for five solid tumour sites in Catalonia from 2009 to 2018. Institut d'Investigació en Atenció Primària Jordi Gol i Gurina (IDIAPJGol). 2022 IP: Talita Duarte Salles.

  • The descriptive epidemiology of Adverse Events of Special Interest for COVID-19 and other vaccines and after seasonal influenza and COVID-19 disease in SIDIAP. Institut d'Investigació en Atenció Primària Jordi Gol i Gurina (IDIAPJGol). 2021 IP: Talita Duarte Salles.

  • The appropriateness of prescribing antibiotics in primary health care in Europe with respect to antibiotic resistance. (223083). European Commission; Fundació d'Atenció Primària (FAP) - CAMFIC; Institut d'Investigació en Atenció Primària Jordi Gol i Gurina (IDIAPJGol). 2009-2023. IP: Anna Berenguera Ossó, Bonaventura Bolíbar Ribas.

  • Systemic glucocorticoids in the treatment of COVID-19 and risks of adverse outcomes in COVID-19 patients in the primary and secondary care setting. IQVIA Solutions BV. 2021 IP: Talita Duarte Salles.

  • Study of the drivers of late diagnosis of alcohol related disease, alone or in combination with metabolic-dysfunction associated fatty liver disease (MAFLD), and implementation and evaluation of interventions to reduce its burden (StopALD). (73890067-40). Institut Municipal Hisenda BCN - AJUNTAMENT DE BARCELONA. 2022-2024. IP: Anna Berenguera Ossó.

  • Study of exposure and use patterns of alternatives to ranitidine-containing medicines in patients treated with ranitidine. IQVIA Solutions BV. 2022 IP: Talita Duarte Salles.

  • Self-controlled case series (SCCS) study of COVID-19 vaccines and myocarditis and pericarditis (GVDN-VAC4EU-Myocarditis). 2022-2024. IP: Felipe Villalobos Martínez.

  • Salud menstrual, salud mental y calidad de vida en España: estudio de métodos mixtos y participativo para la cocreación de una guía basada en evidencia. (PI22/01389). Instituto de Salud Carlos III. 2022 IP: Anna Berenguera Ossó.

  • Safety of Paxlovid during pregnancy (C4671037, VAC4EU & SIGMA study). Research Triangle Institute (RTI). 2023 IP: Maria Giner Soriano.

  • Safety of Paxlovid among patients with moderate or severe hepatic or renal impairment (C4671047, VAC4EU & SIGMA study). Research Triangle Institute (RTI). 2023 IP: Maria Giner Soriano.

  • Risk of mental and behavioral disorders in relation to availability of green spaces. Institut d'Investigació en Atenció Primària Jordi Gol i Gurina (IDIAPJGol). 2021 IP: Talita Duarte Salles.

  • Risk of Guillain-Barré syndrome (GBS) after COVID-19 vaccination and SARS-CoV-2 infection: A self-controlled risk interval study. 2022-2024. IP: Felipe Villalobos Martínez.

  • Retrospective Longitudinal Study on Edoxaban in Patients with Non-Valvular Atrial Fibrillation in Europe. Syneos Health Consulting INC. 2021 IP: Maria Giner Soriano.

  • Residential outdoor play spaces and children's diagnosed mental and behavioural disorders: the role of individual and area-level socio economic characteristics. Institut d'Investigació en Atenció Primària Jordi Gol i Gurina (IDIAPJGol). 2020-2023. IP: Talita Duarte Salles.

  • Research Protocol for an Observational Health Data Analysis to Assess the Long-term Outcomes of Prostate Cancer Patients Undergoing Non-Interventional Management (i.e., Watchful Waiting) and the Impact of Comorbidities and Life Expectancy - PIONEER IMI's "Big Data for Better Outcomes" program. STICHTING EUROPEAN UROLOGICAL FOUNDATION. 2021 IP: Talita Duarte Salles.

  • Real-world coverage and effectiveness of COVID-19 vaccines in vulnerable populations living in Catalonia. Institut d'Investigació en Atenció Primària Jordi Gol i Gurina (IDIAPJGol). 2023IP:Talita Duarte Salles.

  • Real world trends in surgical procedures- an international network study. University of Oxford. 2021 IP: Talita Duarte Salles.

  • Rapid Safety Assessment of SARS-CoV-2 vaccines in EU Member States using electronic health care datasources (WP3). Vaccine Monitoring Collaboration for Europe (VAC4EU). 2021-2025. IP: Felipe Villalobos Martínez.

  • Professionals, health care workers healthy and infected with SARS-CoV2 long-term incidence, reinfection, serological protection and impact of vaccination: The ProHEpiC-19+ Cohort study. ICS - Institut Català de la Salut. 2021 IP: Concepció Violán Fors.

  • Prevalence of rare blood cancers in Europe - DARWIN - Rare Blood Cancers (C01-001). ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (ERASMUS MC). 2022-2024. IP: Talita Duarte Salles.

  • Preliminary signal assessment in VigiBase enhanced by longitudinal observational health data: the EHDEN pharmacovigilance use case. Institut d'Investigació en Atenció Primària Jordi Gol i Gurina (IDIAPJGol). 2022 IP: Carlen Reyes Reyes.

  • Post-Conditional Approval Active Surveillance Study Among Individuals in Europe Receiving the Pfizer-BioNTech Coronavirus sease 2019 (COVID -19) Vaccine. Fondazione Penta ONLUS. 2021-2024. IP: Felipe Villalobos Martínez.

  • Post-Authorization Active Surveillance Safety Study Using Secondary Data to Monitor Real-World Safety of Spikevax in Europe. ICS - Institut Català de la Salut; Julius Clinical Research B.V. 2021-2024. IP: Felipe Villalobos Martínez.

  • Post-authorisation Safety Study of Rimegepant in Patients with Migraine and History of Cardiovascular Disease in European Countries. Research Triangle Institute (RTI). 2022-2025. IP: Maria Giner Soriano.

  • Post-Authorisation Safety Study of AZD1222. A post-authorisation/post-marketing observational study to evaluate the association between exposure to AZD1222 and safety concerns using existing secondary health data sources. Research Triangle Institute - USA. IP: Maria Giner Soriano.

  • Post-Authorisation Safety Study of AZD1222. A post-authorisation/post-marketing observational study to evaluate the association between exposure to AZD1222 and safety concerns using existing secondary health data sources. Research Triangle Institute (RTI). 2021 IP: Maria Giner Soriano.

  • Population-based study of the effectiveness of combined LAMA / LABA versus LABA / ICS therapy as maintenance treatment in COPD patients in primary care. Boehringer Ingelheim España, S.A. 2021IP:Mònica Monteagudo Zaragoza.

  • Musculoskeletal adverse outcomes after treatment with aromatase inhibitors for breast cancer: a SIDIAP-OHDSI based cohort study. University of Oxford. 2020-2023. IP: Talita Duarte Salles.

  • Multimorbilidad en el Sistema Nacional de Salud: Caracterización poblacional e impacto de sus patrones y trayectorias en personas mayores (Proyecto MM-SNS). (PI22/01398). Instituto de Salud Carlos III. 2022-2025. IP: Concepció Violán Fors.

  • Monitoring safety of Spikevax in pregnancy: an observational study using routinely collected health data in five European countries. Julius Clinical Research B.V. 2021-2024. IP: Felipe Villalobos Martínez.

  • Menstrual health and period poverty among young people who menstruate in the Barcelona metropolitan area (Spain). La Trastienda Comunicación, S.L. 2019-2024. IP: Laura Medina Perucha.

  • Mechanisms of long-COVID and effect of COVID-19 vaccination on long-COVID. Fundacio Privada Daniel Bravo Andreu. 2021 IP: Anna Berenguera Ossó.

  • Large-scale evidence generation and evaluation across a network of databases for type 2 diabetes mellitus. University of California, Los Angeles campus (UCLA). 2022 IP: Talita Duarte Salles.

  • La salud mental en adolescente y jóvenes de Cataluña desde una perspectiva de género: estudio poblacional y cualitativo participativo. (PI22/01278). Instituto de Salud Carlos III. 2022 IP: Constanza Jacques Aviñó.

  • La salud emocional adolescente desde una perspectiva crítica: foto-elicitación en el Raval. 2023-2025. IP: Constanza Jacques Aviñó.

  • Infecció post-vacunal per SARS-CoV2: Estudi de cohort per la caracterització de la resposta immune i desenvolupament d'un model de predicció per establir criteris de revacunació a Catalunya (BreakCOVID). (SLT021/21/000038). Generalitat Catalunya.Departament de Salut. 2022 IP: Concepció Violán Fors.

  • Incidencia y factores de riesgo de la Covid-19 en pacientes respiratorios crónicos. Institut d'Investigació en Atenció Primària Jordi Gol i Gurina (IDIAPJGol). 2021 IP: Mònica Monteagudo Zaragoza.

  • Impact of EU label changes fluoroquinolone containing medicinal products for systemic and inhalation use: post-referral prescribing trends (IQVIA). IQVIA Solutions BV. 2021 IP: Talita Duarte Salles.

  • IMMunE Response against SARS-CoV-2 an ageIng community pOpulation in Northern of Metropolitana area of Barcelona (IMMERSION). ICS - Institut Català de la Salut. 2021-2023. IP: Concepció Violán Fors.

  • Hemorràgies majors en pacients tractats amb anticoagulants i interaccions farmacològiques: estudi cas-control amb dades de la història clínica d'Atenció Primària a Catalunya. 2023-2026. IP: Maria Giner Soriano.

  • Genetic Evaluation of Multimorbidity towards INdividualisation of Interventions. National Institute for Health Research. 2020-2023. IP: Concepció Violán Fors.

  • Examining the etiology of early-onset colorectal cancer (EOCRC) in the SIDIAP database - research protocol. International Agency for Research on Cancer (IARC). 2021 IP: Talita Duarte Salles.

  • Evaluación cualitativa de la implementación de una intervención compleja para el cribado de población inmigrante en el ámbito de la atención primaria. Consorci d'Atenció Primària de Salut Barcelona Esquerre (CAPSBE). 2019-2023. IP: Alessandra Queiroga Gonçalves.

  • European Non-interventional Post Authorization Safety Study for romosozumab by the EU-ADR Alliance. 2018-2026. IP: Carlen Reyes Reyes.

  • Estudio de asociación entre antihistamínicos y supervivencia del cáncer (Antihistamines to improve cancer care). ICS - Institut Català de la Salut. 2021-2023. IP: Concepció Violán Fors.

  • Estudi descriptiu sobre la migranya. Institut d'Investigació en Atenció Primària Jordi Gol i Gurina (IDIAPJGol). 2023IP:Maria Giner Soriano.

  • Estudi descriptiu de les característiques clíniques i l'abordatge terapèutic dels factors de risc cardiovascular al debut de la diabetis tipus 2 (DM2) en funció del sexe en una cohort d'atenció primària a Catalunya. 2022-2025. IP: Anna Mª Ramírez Morros.

  • Estudi de resultats en salut en diabetis mellitus tipus 2. Institut d'Investigació en Atenció Primària Jordi Gol i Gurina (IDIAPJGol). 2021IP:Maria Giner Soriano.

  • Estudi de l'impacte de la pandèmia per Sars-CoV-2 en les cobertures vacunals a Catalunya. ICS - Institut Català de la Salut. 2022 IP: Edurne Zabaleta del Olmo.

  • Epidemiology and burden of imminent subsequent fractures in postmenopausal women. University of Oxford. 2023 IP: Carlen Reyes Reyes.

  • El poder de la imagen. Investigación Acción Participativa con jóvenes procedentes de contextos interculturales de Santiago de Chile. Facultat de Medicina de la Universidad de Chile. 2022-2024. IP: Constanza Jacques Aviñó.

  • Effects of temperature and air pollution on mental health in Barcelona and its metropolitan area considering sociodemographic and geographical inequalities. (74036228-32). Institut Municipal Hisenda BCN - AJUNTAMENT DE BARCELONA. 2022-2024. IP: Talita Duarte Salles.

  • Effects of Angiotensin-converting enzyme Inhibitors and Angiotensin receptor blockers: protocol for a Spanish cohort study using routinely collected electronic health records with validation against the ONTARGET trial. London School of Hygiene & Tropical Medicine. 2022. IP: Carlen Reyes Reyes.

  • Effectiveness of heterologous and booster Covid-19 vaccination in 5 European countries, using a cohort approach in children and adults with a full primary Covid-19 vaccination regimen. UMC Utrecht (University Medical Center Utrecht). 2022-2024. IP:  Felipe Villalobos Martínez.

  • Efectividad de una intervención formativa para mejorar el abordaje de los pacientes con vértigo en atención primaria. Ensayo clínico VERTAP. (PI19/00736). Instituto de Salud Carlos III. 2019-2024. IP:  Luis Ballvé Moreno.

  • Drug Utilization Study (DUS) and Post Authorization Safety Study (PASS) on the fixed combination tramadol-dexketoprofen (DKP-TRAM). SIMG - Società Italiana di Medicina Generale e delle cure primarie; SIMG SERVICE CONGRESS AND EDUCATION S.R.L. 2021. IP: Talita Duarte Salles.

  • Drug utilisation studies using data mapped to the OMOP Common Data Model: a proof of concept study assessing respiratory drug use in patients with asthma or COPD. ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (EMC). 2021. IP: Talita Duarte Salles.

  • Drug utilisation of valproate-containing medicinal products in women of childbearing potential. ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (EMC). 2022-2024. IP: Talita Duarte Salles.

  • Desarrollo de un modelo predictivo de falta de adherencia terapéutica en el contexto del proyecto BEAMER. 2023-2026. IP: Maria Giner Soriano.

  • DARWIN EU® - Use of take-home naloxone for opioid overdose treatment. ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (EMC). 2023-2024. IP: Talita Duarte Salles.

  • DARWIN EU® - Treatment patterns of drugs used in adult and paediatric population with systemic lupus erythematosus. ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (EMC). 2023. IP: Talita Duarte Salles.

  • DARWIN EU® - Natural history of dermatomyositis (DM) and polymyositis (PM) in adults and paediatric populations. ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (EMC). 2023-2024. IP: Talita Duarte Salles.

  • DARWIN EU® - Multiple myeloma: patient characterisation, treatments and survival in the period 2012-2022. 2023-2024. IP: Talita Duarte Salles.

  • DARWIN EU® - Monitoring prescription of medicines for public health emergencies at risk of shortages. ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (EMC). 2023-2025. IP: Talita Duarte Salles.

  • DARWIN EU® - DUS of medicines with prokinetic properties in children and adults diagnosed with gastroparesis. ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (EMC). 2023-2024. IP: Talita Duarte Salles.

  • DARWIN EU® - DUS of Antibiotics in the 'Watch' category of the WHO AWaRe classification of antibiotics for evaluation and monitoring of use. 2022-2024. IP: Talita Duarte Salles.

  • DARWIN EU® - DUS in patients with major depressive disorder. ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (EMC). 2023. IP: Talita Duarte Salles.

  • DARWIN EU® - Drug utilization study of prescription opioids. ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (EMC). 2023-2024. IP: Talita Duarte Salles.

  • DARWIN EU - EHDS Use Case: Natural history of coagulopathy in COVID-19 patients and persons vaccinated against SARS-CoV-2 in the context of the OMICRON variant. ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (EMC). 2023. IP: Talita Duarte Salles.

  • DARWIN EU - Background rates of serious adverse events to contextualise safety signals in a clinical trial in adolescent and adult patients with severe asthma. 2023-2024. IP: Talita Duarte Salles.

  • Construcción y validación de un Score predictivo de riesgo de institucionalización, ingresos hospitalarios y mortalidad, en mayores de 65 años con multimorbilidad y fragilidad - Validación SNAC-K (OMOP). 2023. IP: Concepció Violán Fors.

  • Construcción y validación de un Score predictivo de riesgo de institucionalización, ingresos hospitalarios y mortalidad, en mayores de 65 años con multimorbilidad y fragilidad. (PI19/00535). Instituto de Salud Carlos III. 2019-2023. IP: Concepció Violán Fors.

  • Comparación de la efectividad de fármacos en primera línea de tratamiento preventivo de la migraña en Atención Primaria: ensayo clínico pragmático. Estudio PREMI. (ICI23/00047). Instituto de Salud Carlos III. 2023-2026. IP:Maria Giner Soriano.

  • Comorbidity prevalence between HIV positive and HIV negative patients over 40 years of age. ICS - Institut Català de la Salut. 2021. IP: Concepció Violán Fors.

  • Cohorte DESVELA. Análisis del papel de las aptitudes personales como DEterminantes de la incidencia de morbilidad, eStilos de vida, calidad de Vida, uso de sErvicios y mortaLidAd. (PI19/01285). Instituto de Salud Carlos III. 2019-2024. IP:  Diana Puente Baliarda, Bonaventura Bolíbar Ribas.

  • Cohort Event Monitoring of safety of COVID-19 vaccines in special populations (pregnant and lactating women, children and adolescents, immunocompromised, people with history of allergy, people with prior SARS-CoV-2 infection) (WP1). European Medicines Agency (EMA). 2021-2024. IP: Felipe Villalobos Martínez.

  • Clinical course, outcomes and risk factors of myocarditis following administration of mRNA-1273 (ELASOMERAN). Julius Clinical Research B.V. 2023-2025. IP: Felipe Villalobos Martínez.

  • Characterisation and risks of long-term COVID-19 outcomes using large real world data. Instituto de Salud Carlos III. 2022. IP:  Talita Duarte Salles.

  • Avaluació d'una intervenció educativa d'equitat menstrual a centres d'educació secundària a Catalunya: projecte de metodologia mixta. Institut Català de les Dones. 2022-2024. IP: Laura Medina Perucha.

  • Avaluació d'un programa interdisciplinar optimitzat per millorar la qualitat de vida de les persones amb fibromiàlgia: estudi quasiexperimental (FIBROcatcentral). 2023-2026. IP: Glòria Saüch Valmaña.

  • Atención centrada en la persona y calidad de vida en mujeres con dispareunia. (PIFIISC22/28). Fundación Canaria Instituto de Investigación Sanitaria de Canarias. 2023. IP: Laura Medina Perucha.

  • Associations between playspaces and childhood overweight and obesity in Barcelona. Institut d'Investigació en Atenció Primària Jordi Gol i Gurina (IDIAPJGol). 2021. IP: Talita Duarte Salles.

  • An Observational Post-Authorization Safety Study to Assess the Safety of Ad26.COV2.S Using European Healthcare Data through VAC4EU. TEAMIT INSTITUTE, S.L. 2021-2024. IP: Felipe Villalobos Martínez.

  • Air pollution in relation to COVID-19 morbidity and mortality: a large population-based cohort study in Catalonia, Spain (COVAIR-CAT). Fundación Privada Instituto de Salud Global Barcelona (ISGlobal). 2022. IP: Talita Duarte Salles.

  • Adaptació i validació de la "Practice Environment Scale of the Nursing Work Index" al context organitzatiu dels equips d'Atenció Primària de salut i penitenciària de l'Institut Català de la Salut. 2022 IP: Edurne Zabaleta del Olmo.

  • Post-Authorisation Active Surveillance Study of Myocarditis and Pericarditis Among Individuals in Europe Receiving the Pfizer-BioNTech Coronavirus Disease 2019 (COVID 19) Vaccine. Fondazione Penta ONLUS. 2022-2025. IP: Felipe Villalobos Martínez.

  • Estudio posautorización de seguridad (EPAS) no intervencionista para la vigilancia activa de la seguridad de los receptores de la vacuna de ARNm contra la COVID-19 de Pfizer-BioNTech en la UE. Pfizer, S.A. 2021. IP: Felipe Villalobos Martínez.

  • Drug Utilization Study Evaluating Additional Risk Minimization Measures for Upadacitinib in the Treatment of Atopic Dermatitis in Europe. Abbvie INC. IP: Talita Duarte Salles.

Group publications

JOURNAL PUBLICATIONS

  • Pou MA, Martinez Laguna D, Estebanez JL, Aivar M, Gayarre R, Conesa A et al. Validation of gout diagnosis in electronic primary care medical records: A population-based study. Jt. Bone Spine. 2023;90(6):105628-105628. PMID:37634875.

  • Fernández García S, Moreno AM, Giner Soriano M, Morros R, Ouchi D, García Sangenís A et al. Urinary Tract Infections in Men in Primary Care in Catalonia, Spain. Antibiotics-Basel. 2023;12(11):PMID:37998813.

  • Sanchez Durán MA, Maiz N, Liutsko L, Bielsa Pascual J, García Sierra R, Zientalska AM et al. Universal screening programme for cytomegalovirus infection in the first trimester of pregnancy: study protocol for an observational multicentre study in the area of Barcelona (CITEMB study). BMJ Open. 2023;13(7):PMID:37474185.

  • Raventos B, Fernandez Bertolin S, Aragon M, Voss EA, Blacketer C, Mendez Boo L et al. Transforming the Information System for Research in Primary Care (SIDIAP) in Catalonia to the OMOP Common Data Model and Its Use for COVID-19 Research. Clin. Epidemiol. 2023;15969-986. PMID:37724311.

  • Bennett M, Pistillo A, Recalde M, Reyes C, Freisling H, Duarte Salles T. Time trends in the incidence of cardiovascular disease, hypertension and diabetes by sex and socioeconomic status in Catalonia, Spain: a population-based cohort study. BMJ Open. 2023;13(5):PMID:37225269.

  • Ribas BB, Llobera Cànaves J, García Ortiz L, Bellón JA, Ramos R, García Campayo J et al. The Research Network on Preventive Activities and Health Promotion (redIAPP): a reference network and promoter of primary care research. Aten. Prim. 2023;55(11):102694-102694. PMID:37481824.

  • Collatuzzo G, De Palma G, Violante FS, Porru S, Filon FL, Fabianova E et al. Temporal trends of COVID-19 antibodies in vaccinated healthcare workers undergoing repeated serological sampling: an individual-level analysis within 13 months in the ORCHESTRA cohort (vol 13, 1079884, 2023). Front. Immunol. 2023;141197923-1197923. PMID:37122701.

  • Collatuzzo G, De Palma G, Violante FS, Porru S, Filon FL, Fabianova E et al. Temporal trends of COVID-19 antibodies in vaccinated healthcare workers undergoing repeated serological sampling: An individual-level analysis within 13 months in the ORCHESTRA cohort. Front. Immunol. 2023;131079884-1079884. PMID:36713452.

  • Gauffin O, Brand JS, Vidlin SH, Sartori D, Asikainen S, Català M et al. Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study. Drug Saf. 2023;46(12):1335-1352. PMID:37804398.

  • Aragones E, Rodoreda S, Guitart M, Garcia E, Berenguera A, Martin F et al. Study protocol: assessment of the usefulness and practicability of a psychoeducational intervention to prevent the negative psychological impact of the COVID-19 pandemic on primary care health workers. BMC Prim. Care. 2023;24(1):231-231. PMID:37925394.

  • Medina Perucha L, Jacques Avino C, Lopez Jimenez T, Maiz C, Berenguera A. Spanish residents' experiences of care during the first wave of the COVID-19 syndemic: a photo-elicitation study. Int. J Qual. Stud. Health Well-being. 2023;18(1):2172798-2172798. PMID:36779532.

  • Salas Quijada C, López Contreras N, López Jiménez T, Medina Perucha L, León Gómez BB, Peralta A et al. Social Inequalities in Mental Health and Self-Perceived Health in the First Wave of COVID-19 Lockdown in Latin America and Spain: Results of an Online Observational Study. Int J Environ Res Public Health. 2023;20(9):PMID:37174240.

  • Giner Soriano M, Prat Vallverdu O, Ouchi D, Vilaplana Carnerero C, Morros R. Sex and gender differences in the use of oral anticoagulants for non-valvular atrial fibrillation: A population-based cohort study in primary health care in catalonia. Front. Pharmacol. 2023;141110036-1110036. PMID:36825151.

  • Arshad F, Schuemie MJ, Bu F, Minty EP, Alshammari TM, Lai LYH et al. Serially Combining Epidemiological Designs Does Not Improve Overall Signal Detection in Vaccine Safety Surveillance. Drug Saf. 2023;46(8):797-807. PMID:37328600.

  • Evangelidou S, Cruz A, Osorio Y, Sequeira Aymar E, Gonçalves AQ, Camps Vila L et al. Screening and routine diagnosis of mental disorders among migrants in primary care: A cross-sectional study. J. Migr. Health. 2023;8100205-100205. PMID:38047139.

  • Young Silva Y, Berenguera A, Jacques Aviño C, Gil Girbau M, Arroyo Uriarte P, Chela Alvarez X et al. Role of personal aptitudes as determinants of incident morbidity, lifestyles, quality of life, use of the health services and mortality (DESVELA cohort): qualitative study protocol for a prospective cohort study in a hybrid analysis. Front. Public Health. 2023;111069957-1069957. PMID:37361167.

  • Martí Lluch R, Bolibar B, Llobera J, Maderuelo Fernández JA, Magallón Botaya R, Sánchez Pérez A et al. Role of personal aptitudes as determinants of incident morbidity, lifestyles, quality of life, use of health services, and mortality (DESVELA cohort): quantitative study protocol for a prospective cohort study in a hybrid analysis. Front. Public Health. 2023;111067249-1067249. PMID:37427254.

  • Zabaleta Olmo E, Santesmases Masana R, Martín Payo R, Romero Collado A, Zamora Sánchez JJ, Urpí Fernández AM et al. Research on missed nursing care during the COVID-19 pandemic: A scoping review. Worldviews Evid.-Based Nurs. 2023;20(6):559-573. PMID:37743584.

  • Méndez López F, Camarero Grados L, Moleras Serra A, Heah R, Porroche Escudero A, Sánchez Arizcuren R. Relationship between the inductive or deductive approach to case-based learning on academic performance, self-efficacy, and satisfaction of social work students. Acciones Invest. Soc. 2023;(44):90-103.

  • You SC, Seo SI, Falconer T, Yanover C, Duarte Salles T, Seager S et al. Ranitidine Use and Incident Cancer in a Multinational Cohort. JAMA Netw Open. 2023;6(9):2333495-PMID:37725377.

  • Lejeune M, Reverte L, Sauras E, Gallardo N, Bosch R, Roso A et al. Prognostic Implications of the Residual Tumor Microenvironment after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients without Pathological Complete Response. Cancers. 2023;15(3):PMID:36765559.

  • Moleras Serra A, Morros Pedros R, Monteagudo M, Vedia Urgell C, Gomez Lumbreras A. Primary health care research in COVID-19: analysis of the protocols reviewed by the ethics committee of IDIAPJGol, Catalonia. BMC Prim. Care. 2023;24(1):91-91. PMID:37024845.

  • Carrasco Ribelles LA, Llanes Jurado J, Gallego Moll C, Cabrera Bean M, Monteagudo Zaragoza M, Violán C et al. Prediction models using artificial intelligence and longitudinal data from electronic health records: a systematic methodological review. J. Am. Med. Informatics Assoc. 2023;30(12):2072-2082. PMID:37659105.

  • Obiols PC, Miranda Mendizabal A, Recoder S, Sebastian EC, Casajuana Closas M, Leiva D et al. Physical and mental health impact of the COVID-19 pandemic at first year in a Spanish adult cohort. Sci Rep. 2023;13(1):4547-4547. PMID:36941282.

  • Montesó Curto P, Toussaint L, Kueny A, Ruschak I, Lunn S, Rosselló L et al. Physical Activity and Exercise Experience in Spanish and US Men with Fibromyalgia: A Qualitative Cross-Cultural Study. Int J Environ Res Public Health. 2023;20(18):PMID:37754590.

  • Jacques Aviñó C, Medina Perucha L, Young Silva Y, Granés L, Lòpez Jiménez T, Berenguera A. Narratives on changes in health-related behaviours during lockdown in Spain according to gender. Gac. Sanit. 2023;37102296-102296. PMID:36921453.

  • de Homdedeu M, Sanchez Moral L, Violan C, Ràfols N, Ouchi D, Martín B et al. Mycobacterium manresensis induces trained immunity in vitro. iScience. 2023;26(6):106873-106873. PMID:37250788.

  • Khera R, Dhingra LS, Aminorroaya A, Li K, Zhou JJ, Arshad F et al. Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM. BMJ Med. 2023;2(1):PMID:37829182.

  • Valletta M, Vetrano DL, Xia X, Rizzuto D, Roso Llorach A, Calderón Larrañaga A et al. Multimorbidity patterns and 18-year transitions from normal cognition to dementia and death: A population-based study. J. Intern. Med. (GBR). 2023;294(3):326-335. PMID:37306092.

  • Violán C, Carrasco Ribelles LA, Collatuzzo G, Ditano G, Abedini M, Janke C et al. Multimorbidity and Serological Response to SARS-CoV-2 Nine Months after 1st Vaccine Dose: European Cohort of Healthcare Workers-Orchestra Project. Vaccines. 2023;11(8):PMID:37631908.

  • Medina Perucha L, López Jiménez T, Jacques Aviñó C, Holst AS, Valls Llobet C, Munrós Feliu J et al. Menstruation and social inequities in Spain: a cross-sectional online survey-based study. Int. J. Equity Health. 2023;22(1):92-92. PMID:37198680.

  • Holst AS, Jacques Aviñó C, Berenguera A, Martínez Bueno C, Munrós Feliu J, Pinzón Sanabria D et al. Menstrual health and management during the COVID-19 syndemic in the Barcelona area (Spain): A qualitative study. Women's Health. 2023;19PMID:37092568.

  • Lejeune M, Reverté L, Gallardo N, Sauras E, Bosch R, Mata D et al. Matrix Metalloproteinase-9 Expression Is Associated with the Absence of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients. Int. J. Mol. Sci. 2023;24(14):PMID:37511057.

  • Ranzani O, Alari A, Olmos S, Milà C, Rico A, Ballester J et al. Long-term exposure to air pollution and severe COVID-19 in Catalonia: a population-based cohort study. Nat Commun. 2023;14(1):2916-2916. PMID:37225741.

  • Ouchi D, Giner Soriano M, Vilaplana Carnerero C, Monfa R, Torres F, Morros R. Longitudinal treatment patterns in patients recently diagnosed with type 2 diabetes mellitus in Catalonia. Diabetes Res. Clin. Pract. 2023;202110777-110777. PMID:37321303.

  • Recalde M, Pistillo A, Davila Batista V, Leitzmann M, Romieu I, Viallon V et al. Longitudinal body mass index and cancer risk: a cohort study of 2.6 million Catalan adults. Nat Commun. 2023;14(1):3816-3816. PMID:37391446.

  • Gavaldà Espelta E, Lleixà Fortuño MD, Baucells Lluis J, Ferré Ferraté M, Tomàs Navarro B, Curto Romeu C et al. Innovative Health and Social Integrated Care Model Effectiveness to Improve Quality Care for Chronic Patients: A Single Group Assignment Clinical Trial. Int. J. Integr. Care. 2023;23(4):2-2. PMID:37842263.

  • Raventós B, Català M, Du MK, Guo YC, Black A, Inberg G et al. IncidencePrevalence: An R package to calculate population-level incidence rates and prevalence using the OMOP common data model. Pharmacoepidemiol. Drug Saf. 2023;33(1):PMID:37876360.

  • Porru S, Monaco MGL, Spiteri G, Carta A, Caliskan G, Violán C et al. Incidence and Determinants of Symptomatic and Asymptomatic SARS-CoV-2 Breakthrough Infections After Booster Dose in a Large European Multicentric Cohort of Health Workers-ORCHESTRA Project. J. Epidemiol. Global Health. 2023;13(3):577-588. PMID:37480426.

  • Montserrat Capdevila J, Fornells Barberà I, Roso Llorach A, Olivares Sanzo P, Romero Gracia A, Ichart JX. Impacto de la COVID-19 en la salud mental de la población: estudio en atención primaria. Aten. Prim. 2024;56(3):102813-102813. PMID:38039619.

  • Martinez Marcos M, Zabaleta Olmo E, Gomez Duran EL, Rene A, Cabezas Pena C. Impact of the COVID-19 lockdown on routine childhood vaccination coverage rates in Catalonia (Spain): a public health register-based study. Public Health. 2023;21868-74. PMID:36972643.

  • Ouchi D, Vilaplana Carnerero C, Monfa R, Giner Soriano M, Garcia Sangenis A, Torres F et al. Impact of Second-Line Combination Treatment for Type 2 Diabetes Mellitus on Disease Control: A Population-Based Cohort Study. Drugs - Real World Outcomes. 2023;10(3):447-457. PMID:37160557.

  • LYNF, Flach C, Lysen TS, Markov E, van Ballegooijen H, Rijnbeek P et al. Impact of European Union Label Changes for Fluoroquinolone-Containing Medicinal Products for Systemic and Inhalation Use: Post-Referral Prescribing Trends. Drug Saf. 2023;46(4):405-416. PMID:36976448.

  • Mollo A, Vlacho B, Gratacos M, Mata Cases M, Rubinat E, Berenguera A et al. Impact of a multicomponent healthcare intervention on glycaemic control in subjects with poorly controlled type 2 diabetes: The INTEGRA study. Diabetes Obes. Metab. 2023;25(4):1045-1055. PMID:36546592.

  • Megido MJ, Celdran M, Ferrer A, Roca M, Pujol Ribera E, Zabaleta Olmo E. Grandchildren of grandparents with Alzheimer's disease: Exploratory study of the impact of the disease on their relationships. Dementia. 2023;22(4):838-853. PMID:36916529.

  • Troncoso Mariño A, Lestón Vázquez M, Gallardo Borge S, Del Val Garcia JL, Amado Guirado E, Violán C. Fracture risk after deprescription of bisphosphonates: Application of real-world data in primary care. Aten. Prim. 2023;55(7):102651-102651. PMID:37187104.

  • Makadia R, Shoaibi A, Rao GA, Ostropolets A, Rijnbeek PR, Voss EA et al. Evaluating the impact of alternative phenotype definitions on incidence rates across a global data network. JAMIA Open. 2023;6(4):PMID:38028730.

  • Máiz Mazuela C, Medina Perucha L, Berenguera A, López Jiménez T, Rodríguez Giralt I, Sepúlveda PC et al. Essential Workers Balancing Life and Work during the COVID-19 Syndemic in Spain: A Qualitative and Gender-Based Study. Health Soc. Care Community. 2023;2023

  • Jacques Aviñó C, Guitiérrez MA, Barbera MJ, Fuertes I, Martin Ezquerra G, Lopez Contreras J et al. Epidemiological Characteristics and Factors Associated with Repeat Sexually Transmitted Infections in Barcelona, Spain Over a Decade. Arch. Sex. Behav. 2023;53(2):735-744. PMID:37875628.

  • Giner Soriano M, Ouchi D, Vives R, Vilaplana Carnerero C, Molina A, Vallano A et al. Effectiveness and safety of oral anticoagulants for non-valvular atrial fibrillation: a population-based cohort study in primary healthcare in Catalonia. Front. Pharmacol. 2023;141237454-1237454. PMID:37781690.

  • Carrasco Querol N, González Serra G, Bueno Hernández N, Gonçalves AQ, Pastor Cazalla M, Bestratén Del Pino P et al. Effectiveness and health benefits of a nutritional, chronobiological and physical exercise primary care intervention in fibromyalgia and chronic fatigue syndrome: SYNCHRONIZE + mixed-methods study protocol. Medicine (Baltimore). 2023;102(17):33637-PMID:37115043.

  • Tan EH, Robinson DE, Joedicke AM, Mosseveld M, Bodkergaard K, Reyes C et al. Drug utilization analysis of osteoporosis medications in seven European electronic health databases. Osteoporosis Int. 2023;34(10):1771-1781. PMID:37436441.

  • Arinze JT, de Ridder M, Vojinovic D, van Ballegooijen H, Markov E, Duarte Salles T et al. Drug Utilisation Patterns of Alternatives to Ranitidine-Containing Medicines in Patients Treated with Ranitidine: A Network Analysis of Data from Six European National Databases. Drug Saf. 2023;46(12):1353-1362. PMID:37907775.

  • Vázquez ML, Vilaplana Carnerero C, Gomez Lumbreras A, Prat Vallverdu O, Marsal JR, Urgell CV et al. Drug exposure during pregnancy in primary care: an algorithm and observational study from SIDIAP database, Catalunya, Spain. BMJ Open. 2023;13(8):PMID:37607789.

  • Moragas Moreno A, Fernández García S, Llor C, Ouchi D, García Sangenís A, Monteagudo M et al. Diagnostic and Therapeutic Management of Urinary Tract Infections in Catalonia, Spain: Protocol for an Observational Cohort Study. JMIR RES. Protoc. 2023;12PMID:36811950.

  • Duenas Espin I, Jacques Avino C, Egas Reyes V, Larrea S, Torres Castillo AL, Trujillo P et al. Determinants of self-reported health status during COVID-19 lockdown among surveyed Ecuadorian population: A cross sectional study. PLoS One. 2023;18(3):PMID:36888623.

  • Leomanni L, Collatuzzo G, Sansone E, Sala E, De Palma G, Porru S et al. Determinants of Anti-S Immune Response at 12 Months after SARS-CoV-2 Vaccination in a Multicentric European Cohort of Healthcare Workers-ORCHESTRA Project. Vaccines. 2023;11(10):PMID:37896931.

  • Arfuch VM, Martín CA, Berenguera A, Angelats RC, Gonçalves AQ, Carrasco Querol N et al. COST-UTILITY OF A MULTICOMPONENT INTERVENTION FOR FIBROMYALGIA VERSUS USUAL CARE: A PRAGMATIC RANDOMISED CONTROLLED TRIAL. J Rehabil Med. 2023;55. PMID:38111994.

  • Carrasco Ribelles LA, Cabrera Bean M, Danes Castells M, Zabaleta Olmo E, Roso Llorach A, Violan C. Contribution of Frailty to Multimorbidity Patterns and Trajectories: Longitudinal Dynamic Cohort Study of Aging People. JMIR Publ. Heal. Surveil. 2023;9. PMID:37368462.

  • Sanjurjo L, Castelblanco E, Julve J, Villalmanzo N, Téllez E, Ramirez Morros A et al. Contribution of Elevated Glucose and Oxidized LDL to Macrophage Inflammation: A Role for PRAS40/Akt-Dependent Shedding of Soluble CD14. Antioxidants. 2023;12(5):PMID:37237950.

  • Voss EA, Shoaibi A, Yin Hui Lai L, Blacketer C, Alshammari T, Makadia R et al. Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study. EClinicalMedicine. 2023;58101932-101932. PMID:37034358.

  • Rosa Dalmau Llorca M, Martín CA, Carrasco Querol N, Rojas ZH, Cumplido DR, Blanco EC et al. Clinical value of a tool for managing oral anticoagulation in nonvalvular atrial fibrillation in primary health care. Randomized clinical trial. Rev Esp Cardiol (Engl Ed). 2024; PMID:38056770.

  • Moreno Martos D, Verhamme K, Ostropolets A, Kostka K, Duarte Sales T, Prieto Alhambra D et al. Characteristics and outcomes of COVID-19 patients with COPD from the United States, South Korea, and Europe. Wellcome Open Res. 2023;7

  • Warkentin S, de Bont J, Abellan A, Pistillo A, Saucy A, Cirach M et al. Changes in air pollution exposure after residential relocation and body mass index in children and adolescents: A natural experiment study?. Environ. Pollut. 2023;334122217-122217. PMID:37467916.

  • León Gómez BB, Moreno Gabriel E, Carrasco Ribelles LA, Fors CV, Liutsko L. Challenges and obstacles of artificial intelligence in health research. Gac. Sanit. 2023;37102315-102315. PMID:37418947.

  • Llamas Reinero E, Vicente Hernández MM, Cabedo Ferreiro R, Manresa Domínguez JM, García Acosta M, Martínez Bueno C et al. Características de las mujeres migradas atendidas por los Servicios de Salud Reproductiva del Institut Català de la Salut. Rev Esp Salud Publica. 2023;97PMID:36883555.

  • Recalde M, Pistillo A, Viallon V, Fontvieille E, Duarte Salles T, Freisling H. Body mass index and incident cardiometabolic conditions in relation to obesity-related cancer risk: A population-based cohort study in Catalonia, Spain. Cancer Med. 2023;12(19):20188-20200. PMID:37766588.

  • Heumann M, Röhnsch G, Zabaleta Olmo E, Toso BRGD, Giovanella L, Hämel K. Barriers to and enablers of the promotion of patient and family participation in primary healthcare nursing in Brazil, Germany and Spain: A qualitative study. Health Expect. 2023;26(6):2396-2408. PMID:37565592.

  • Ponjoan A, Jacques Avino C, Medina Perucha L, Romero V, Marti Lluch R, Alves Cabratosa L et al. Axes of social inequities in COVID-19 clinical trials: A systematic review. Front. Public Health. 2023;111069357-1069357. PMID:36891333.

  • Vilaplana Carnerero C, Giner Soriano M, Dominguez A, Morros R, Pericas C, Alamo Junquera D et al. Atherosclerosis, Cardiovascular Disease, and COVID-19: A Narrative Review. Biomedicines. 2023;11(4):PMID:37189823.

  • Abiétar DG, Domingo L, Medina Perucha L, Saavedra N, Berenguera A, Lacueva L et al. A qualitative exploration of patient safety in a hospital setting in Spain: Policy and practice recommendations on patients' and companions' participation. Health Expect. 2023;26(4):1536-1550. PMID:36971145.

  • Raya Tena A, Martin Royo J, Bellido Perez M, Valmana GS, Osso AB, Soria Garcia MD et al. A primary care psychoeducational group intervention for patients with depression and physical comorbidity: A qualitative study with a gender perspective. Int. J. Nurs. Pract. 2023;29(6):PMID:37127403.

  • Gomez I, Motrico E, Moreno Peral P, Casajuana Closas M, Lopez Jimenez T, Zabaleta Olmo E et al. A multiple health behaviour change intervention to prevent depression: A randomized controlled trial. Gen. Hosp. Psychiatry. 2023;8286-94. PMID:37001428.

  • Mollo A, Vlacho B, Gratacos M, Mata Cases M, Rubinat E, Osso AB et al. A multicomponent health care intervention is associated with improved glycaemic control in subjects with poorly controlled type 2 diabetes compared with routine care: The INTEGRA study. Diabetes Obes. Metab. 2023;25(12):3549-3559. PMID:37608473.

  • Kostka K, Roel E, Trinh NTH, Mercadé Besora N, Delmestri A, Mateu L et al. "The burden of post-acute COVID-19 symptoms in a multinational network cohort analysis". Nat Commun. 2023;14(1):7449-7449. PMID:37978296.

PROCEEDING PAPERS

  • Arinze JT, de Ridder M, Duarte Salles T, Sabaté MC, Delmestri A, Omulo H et al. Use of antibiotics in the 'watch' category of the WHO AWaRe classification in Europe: A DARWIN-EU® multinational network cohort study (EUPAS103381). Pharmacoepidemiol. Drug Saf. 2023;32148-149.

  • Reyes C, Newby D, Burn E, Raventós B, Duarte Salles T. Trends in the prescription of anti-dementia treatments in Spain and the UK: A large network population-based cohort study. Pharmacoepidemiol. Drug Saf. 2023;32367-367.

  • Peguero Rodriguez E, Perez Patiño J, Ballve JL, Villar I, Rando Y, Almeda J et al. Starting point for improving the approach to vertigo in primary care. Br. J. Gen. Pract. 2023;73PMID:37479255.

  • Lóez Sánchez I, Raventós B, Roel E, Duarte Salles T. Socioeconomic inequalities in vaccine uptake among children and adolescents in Catalonia, Spain. Gac. Sanit. 2023;37158-158.

  • López Contreras N, Quijada CS, López Jiménez T, Medina Perucha L, León Gómez BB, Peralta A et al. Social inequalities in mental health and self-perceived health in the first wave of covid-19 confinement in latin america and spain: an online observational study. Gac. Sanit. 2023;37186-187.

  • García Egea A, Jacques Aviñó C, Berenguera A, Baroja Benlliure J, Pinzón Sanabria D, Valls Llobet C et al. Perspectives on menstrual health and equity in men in barcelona: a qualitative study. Gac. Sanit. 2023;37149-149.

  • Pistillo A, Warkentin S, Abellan A, Cirach M, Perramon Malavez A, Nieuwenhuijsen M et al. Patterns of environmental exposures related to residential relocation in catalonia: a quasi-experimental study. Gac. Sanit. 2023;37127-127.

  • López Jiménez T, Plana Ripoll O, Duarte Salles T, Recalde M, Bennett M, Puente D. Metabolic syndrome components and cancer risk in catalonia: a large population-based cohort study. Gac. Sanit. 2023;37231-231.

  • Vásquez Vera C, Fernández A, Sánchez Ledesma E, Bennett M, Borrell C. Meanings and uses of housing for daily life and health: gender inequalities from an intersectional perspective. Gac. Sanit. 2023;37125-125.

  • Kostka K, Roel E, Trinh N, Delmestri A, Mateau L, Paredes R et al. Long COVID symptoms following primo- versus reinfection: A multinational cohort analysis of primary care records from Catalonia and the UK. Pharmacoepidemiol. Drug Saf. 2023;32205-206.

  • Raventós B, Reyes C, Aragonès E, Newby D, Mayer MA, Prieto Alhambra D et al. Impact of the covid-19 pandemic on prescription trends of psychotropic medications. Gac. Sanit. 2023;37120-121.

  • Warkentin S, Pistillo A, Abellan A, Raventós B, de Bont J, Vrijheid M et al. Impact of the covid-19 pandemic on childhood and adolescent overweight/obesity in Catalonia, Spain. Gac. Sanit. 2023;37251-251.

  • Carmona Cervelló M, León Gómez BB, Lamonja Vicente N, Dacosta Aguayo R, Roger AA, Reynés AF et al. Identification of the impact in people with persistent covid-19 and cognitive complaints. Gac. Sanit. 2023;37249-249.

  • Gómez Lumbreras A, Vilaplana C, Leston VM, Vedia C, Giner Soriano M, Morros R. Hypertension and pregnancy: pharmacologic treatment and pregnancy outcomes. Value Health. 2023;26(6):252-253.

  • Raventos B, Fernández Bertolín S, Weaver J, Blacketer C, Aragón M, Recalde M et al. Establishing and characterizing large COVID-19 cohorts after mapping the information system for research in primary care (SIDIAP) in Catalonia to the OMOP common data model. Pharmacoepidemiol. Drug Saf. 2023;32211-211.

  • Bruguera A, Díaz Y, Carrasco L, Roso Llorach A, Nomah D, Moreno Fornés S et al. Earlier and higher comorbidities in people living with hiv compared to general population in catalonia. Gac. Sanit. 2023;3781-81.

  • Graell AC, Cruz A, Evangelidou S, Aymar ES, Goncalves AQ, Coma E et al. Delivering an innovative multi-disease screening and vaccination tool to high-risk migrant populations (ISMiHealth): Study protocol of a cluster randomised controlled trial. Trop. Med. Int. Health. 2023;28157-157.

  • Voller BA, Tata E, Gallego Moll C, Roso Llorach A, Bowden J, Masoli J et al. An atlas of genetic contributions to multimorbidity. Hum. Hered. 2023;88(SUPPL 1):63-63.

  • Arfuch V, Martín CA, Berenguera A, Angelats RC, Gonçalves AQ, Carrasco Querol N et al. A cost-utility analysis on a multicomponent intervention for fibromyalgia syndrome in Spain. Eur. J. Public Health. 2023;33

THESIS

  • Barrufet C (Autor). Personalized colorectal cancer screening: feasibility assessment of a tailored risk-based approach. [Tesis Doctoral]. UNIVERSIDAD POMPEU FABRA.

  • Villén N (Autor). Patrons de multimorbiditat i polimediació en una cohort de població en majors de 65 anys a Catalunya. [Tesis Doctoral]. UNIVERSIDAD AUTÓNOMA DE BARCELONA. 2023.

  • Checa C (Autor). Insuficiència cardíaca avançada: Impacte dels determinants socials, experiència amb la malaltia i model de gestió d'atenció al pacient. [Tesis Doctoral]. UNIVERSIDAD AUTÓNOMA DE BARCELONA. 2023.

  • Herrero C (Autor). Avaluació de l´exercici físic supervisat en persones amb arteriopatia perifèrica amb un assaig clínic aleatoritzat. [Tesis Doctoral]. UNIVERSIDAD AUTÓNOMA DE BARCELONA.

Anar a l'inici